1. Home
  2. /
  3. Horror Stories

Horror Stories


Apr 4

2019

Pharmacy Benefit Manager Horror Stories — Part V

The Pharmacy Benefit Manager (PBM) industry lobby claims that it successfully achieves drastic price reductions on medications. They say this comes from PBMs negotiating with competing drug companies and by “encouraging consumers to use the most cost-effective drugs.” Setting aside clear evidence that secretive PBM rebates and fees are actually driving drug prices higher,

Read more

Aug 1

2018

Pharmacy Benefit Manager Horror Stories – Part IV

The cautionary tale of the Pharmacy Benefit Manager (PBM) system is a lesson not yet learned. The United States’ health care system continues to be strangled by the dark presence of these ever-growing corporate middlemen, siphoning off billions of dollars in profits while leaving behind pain, suffering, anxiety, and despair for the millions of

Read more

Sep 1

2017

The Real-Life Patient Impact of PBMs: Volume III

The dire consequences of having Pharmacy Benefit Managers (PBMs) within the United States’ health care system continue to be seen, especially by the millions of cancer patients across the nation who must interact with them to access life-saving drugs. Initially established as a way for insurance companies to outsource the management of drug benefits, PBMs

Read more

May 1

2017

The Real-Life Patient Impact of PBMs: Volume II

T here is no shortage of horror stories associated with the increasingly large role that Pharmacy Benefit Managers (PBMs) play in the United States’ health care system. With their numerous offshoots and service lines, PBMs have managed to take on an oligopolistic presence that adversely impacts patients receiving treatments, their health care providers, and everyone

Read more

Apr 1

2017

The Real-Life Patient Impact of PBMs: Volume I

There is growing awareness of the problems and pitfalls with Pharmacy Benefit Managers (PBMs) in the United States health care system. Contracted by insurance carriers to negotiate on their behalf with pharmaceutical companies, these ‘middle men’ corporations have quietly become an unavoidable part of our nation’s health care system. Controlling at least 80 percent

Read more